Mirae Asset Global Investments Co., Ltd. United Therapeutics Corp Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in United Therapeutics Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,647 shares of UTHR stock, worth $1.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,647

Previous 4,279 14.77%

Holding current value

$1.35 Million

Previous $1.36 Million 4.18%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$311.04 - $363.55 $196,577 - $229,763	-632 Reduced 14.77%	3,647 $1.31 Million
Q2 2024 Jul 30, 2024	SELL	$228.26 - $319.04 $1.94 Million - $2.72 Million	-8,510 Reduced 66.54%	4,279 $1.36 Million
Q1 2024 May 01, 2024	BUY	$210.76 - $249.51 $2.7 Million - $3.19 Million	12,789 New	12,789 $2.94 Million
Q4 2021 Feb 08, 2022	SELL	$184.32 - $216.08 $602,726 - $706,581	-3,270 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $103,599 - $123,770	576 Added 21.38%	3,270 $604,000
Q2 2021 Aug 11, 2021	BUY	$170.47 - $211.93 $241,215 - $299,880	1,415 Added 110.63%	2,694 $484,000
Q1 2021 May 13, 2021	BUY	$153.94 - $174.85 $196,889 - $223,633	1,279 New	1,279 $214,000
Q4 2020 Feb 10, 2021	SELL	$101.87 - $151.79 $220,039 - $327,866	-2,160 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$99.9 - $121.13 $45,054 - $54,629	451 Added 26.39%	2,160 $218,000
Q2 2020 Aug 11, 2020	BUY	$92.74 - $125.82 $158,492 - $215,026	1,709 New	1,709 $206,000
Q2 2019 Aug 13, 2019	SELL	$76.06 - $120.81 $136,375 - $216,612	-1,793 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$107.15 - $126.84 $192,119 - $227,424	1,793 New	1,793 $210,000

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.4M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. United Therapeutics Corp Transaction History